Long-term ticagrelor cuts risk of future events after heart attack
Adding the antiplatelet drug ticagrelor to aspirin as long-term therapy after a heart attack significantly reduced the rate of subsequent death from cardiovascular causes, heart attack or stroke, with the benefit appearing ...
Mar 16, 2015